KCNMA1 and pulmonary hypertension: The present study focused on the acute effect of nebulized BK channel opening agent NS1619 on the cardiopulmonary system, i.e. pharmacologically induced changes of right ventricular performance, systemic hemodynamic parameters, and blood gas exchange of rats with experimentally induced pulmonary hypertension.